2016 Half-Year Results

Corporate Pharma&Biotech - Commercial Manufacturing Lonza Pharma& Biotech B2B PHARMA & BIOTECH Commercial Manufacturing, Clinical Development Services, Products (Consumables, Tests, Media, Equipment) Commercial Manufacturing ■ Outsourcing and dual-sourcing trend by the industry is fully intact ■Sales growth again driven by high demand in mammalian manufacturing ■The customer base has broadened further with new contracts of significant length being signed ■Manufacturing of 20 commercial biologics drug substances Jul-16 2016 Half-Year Results - 20 July 2016 9

View entire presentation